Publications by authors named "Saverio Parlongo"

Claim this Profile
P
Prospective study of neuropeptide y as an adverse cardiovascular risk factor in end-stage renal disease.
Carmine Zoccali, Francesca Mallamaci, Giovanni Tripepi, Francesco A Benedetto, Saverio Parlongo

J Am Soc Nephrol· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chlamydia pneumoniae, overall and cardiovascular mortality in end-stage renal disease (ESRD).
Carmine Zoccali, Francesca Mallamaci, Giovanni Tripepi, Saverio Parlongo, Sebastiano Cutrupi

Kidney Int· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuropeptide Y, left ventricular mass and function in patients with end stage renal disease.
Carmine Zoccali, Francesca Mallamaci, Giovanni Tripepi, Francesco A Benedetto, Saverio Parlongo

J Hypertens· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adiponectin is markedly increased in patients with nephrotic syndrome and is related to metabolic risk factors.
Carmine Zoccali, Francesca Mallamaci, Vincenzo Panuccio, Giovanni Tripepi, Sebastiano Cutrupi, Saverio Parlongo

Kidney Int Suppl· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adiponectin in essential hypertension.
Francesca Mallamaci, Carmine Zoccali, Fortunata Cuzzola, Giovanni Tripepi, Sebastiano Cutrupi, Saverio Parlongo

J Nephrol· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic value of troponin T for alterations in left ventricular mass and function in dialysis patients.
Francesca Mallamaci, Carmine Zoccali, Saverio Parlongo, Giovanni Tripepi, Francesco A Benedetto

Kidney Int· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low parathyroid hormone and pentosidine in hemodialysis patients.
Vincenzo Panuccio, Francesca Mallamaci, Giovanni Tripepi, Saverio Parlongo, Sebastiano Cutrupi

Am J Kidney Dis· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Troponin is related to left ventricular mass and predicts all-cause and cardiovascular mortality in hemodialysis patients.
Francesca Mallamaci, Carmine Zoccali, Saverio Parlongo, Giovanni Tripepi, Francesco A Benedetto

Am J Kidney Dis· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Norepinephrine and concentric hypertrophy in patients with end-stage renal disease.
Carmine Zoccali, Francesca Mallamaci, Giovanni Tripepi, Saverio Parlongo, Sebastiano Cutrupi

Hypertension· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease.
Carmine Zoccali, Francesca Mallamaci, Saverio Parlongo, Sebastiano Cutrupi, Francesco Antonio Benedetto

Circulation· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease.
Carmine Zoccali, Francesca Mallamaci, Giovanni Tripepi, Francesco A Benedetto, Sebastiano Cutrupi, Saverio Parlongo

J Am Soc Nephrol· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients.
Carmine Zoccali, Francesca Mallamaci, Francesco Antonio Benedetto, Giovanni Tripepi, Saverio Parlongo

J Am Soc Nephrol· July 2001

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis